Research at Oslo University Hospital

 

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic rsearch, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

 

Latest news

New genotyping service at Oslo University Hospital

 
Aina Rengmark
Aina Rengmark

The Neurogenetic laboratory is now pleased to offer the research community its competence in genotyping. The service is optimal for genotyping of low to moderate number of genetic variants.
Aina Rengmark (photo) is postdoc and responsible for the service facility. “Using optimized assays we can offer very competitive prices”, she says. Normally the total price including labor will be lower than the assay costs for the commonly used TaqMan technology.

 
 

Ceremony Friday November 21st

Ragnar Mørk legacy prize 2014 to Arne Kolstad

 
Arne Kolstad with Harald Stenmark during the ceremony
Arne Kolstad with Harald Stenmark during the ceremony

The 2014 "Dr. Ragnar Mørk's legacy prize" went to Arne Kolstad from the Department of Oncology for his excellent clinical research on lymphoma therapy.
This annual award of NOK 200.000 is given to scientists affiliated to the Norwegian Radium Hospital who have obtained important results within the field of cancer research.
The ceremony took place Friday November 21st in the Research Building at Montebello. Kolstad gave an interesting lecture about the research activities that has earned him the award.

 
 

Oslo University Hospital has award 6 excellent articles for the first half-year of 2014

 
Bjørn Erikstein, managing director OUS
Bjørn Erikstein, managing director OUS

Oslo University Hospital has rewarded six research groups for their excellent papers published during the first half-year of 2014. Each group receives NOK 50.000 for use in further research. The prizes were distributed during the Friday meeting at Ullevål November 21st.
The award winners gave short presentations of the main findings in their respective articles. Managing director Bjørn Erikstein (photo) distributed the awards, and professor Ole M. Sejerstad chaired the meeting.
The six selected articles are of especially high quality, and they present important finding on both-short and long-term scales. The works reflect the good quality and the interdisciplinarity that characterises several research environments at Oslo University Hospital. The research is a fundamental condition for the institution to maintain and strenghten the quality in the patient treatment.

 
 

New book on RNA Interference edited by Mouldy Sioud recently published

 
Mouldy Sioud
Mouldy Sioud

Mouldy Sioud from Department of Immunology at the Institute for Cancer Research is the editor of a new book published November 10th entitled "RNA Interference: Challenges and Therapeutic Opportunities". The book is included in the series "Methods in Molecular Biology, Vol. 1218" and provides readers with recent advances in siRNA design, delivery, targeting and methods to minimize siRNA's unwanted effects. Preclinical and clinical use of synthetic siRNAs, the roles of miRNAs in cancer and the promise of extracellular miRNAs for diagnosis are also covered in this meticulous collection, along with novel methods for identifying endogenous siRNAs and the annotation of small RNA transcriptomes.

 
 

OUS research blog, November

Why are we more allergic than before?

 
K.C. Lødrup Carlsen
K.C. Lødrup Carlsen

The recently launched Oslo University Hospital research blog is the first of this kind among Norwegian health care institutions. The blog acts as a platform for communicating discoveries in medical sciences in a popularised form, as well as serving as a vehicle for the hospital to stay in touch with the community. It will also be used as a channel for voicing the views of the hospital in debates concerning research policies. The blog is in Norwegian. New contributions will appear on the blog every other week, starting with the heads of research at the various divisions writing in turn. The current contribution is by Karin C. Lødrup Carlsen, head of research at the Women and Children's Division.

 
 

“Centrosome and Cilia biology”-project headed by Sebastian Patzke highlighted by "Helse Sør-Øst"

 
S. Patzke
S. Patzke

The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to selected annual research project reports. This week’s highlighted research project is: "From Cilia to Cytokinesis – Impact of Centrosome Dysfunction in Cancer beyond Cell Division" headed by Sebastian Patzke from the Molecular Radiation Biology group (Trond Stokke) at the Department of Radiation Biology at the Institute of Cancer Research, Division of Cancer Medicine, Surgery & Transplantation, Oslo University Hospital.